Crystallization is a well-explored natural phenomenon where atoms or molecules arrange themselves into highly organized solid ...

Abstract: The advent of the global navigation satellite system has greatly enhanced satellite positioning technology, with precise point positioning (PPP) emerging as a prominent technique. Despite ...

Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to ...

To fulfill the 2 Core Courses, take two Core Courses from two different Core Areas. CSE Core Courses are classified into six areas: Introduction to CSE, Computational Mathematics, High Performance ...

This paper introduces the Julia programming language as a dynamic, cost-effective, and efficient framework for implementing structural analysis packages. To achieve this, the finite element method was ...

After months of negotiations with the Chinese, President Trump has announced a Deal on Economic and Trade Relations with China which includes: Agreements on the flow of the precursors used to make ...

The biggest stories of the day delivered to your inbox.

Zohran Mamdani, the Democratic front-runner in the mayor’s race, plans if elected to replace the selective program, which became a symbol of segregation in public schools. By Emma G. Fitzsimmons and ...

A new diagnostic method would confirm sepsis infections earlier, cutting critical hours in the "race against time" to save patients' lives. Publishing in Nature Publishing Journal Digital Medicine, ...

Humble brag: I reckon I could spot a fitness gimmick a mile off. As WH’s Fitness Editor, I spend pretty much all day everyday reading/writing about the latest workout trends. I’m also kind of addicted ...

Kansas Athletics received $300M from donor David Booth to fund stadium upgrades. City incentives and Booth's $75M challenge boost Phase 2 launch confidence. Renovations start post-2025 season; KU ...

Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the cell division cycle 7 (CDC7) inhibitor died in a Phase I trial. The trial (NCT05961839) ...